Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPC.L Regulatory News (WPC)

  • There is currently no data for WPC

Edison issues review on Witan Pacific I.T.

2 Nov 2018 14:32

RNS Number : 2123G
Witan Pacific Investment Trust PLC
02 November 2018
 

 

London, UK, 2 November 2018

Edison issues review on Witan Pacific Investment Trust (WPC)

Witan Pacific Investment Trust (WPC) offers investors broad exposure to Asian equities, including Japan. While global equities, and emerging markets in particular, have sold off in recent months, the trust's managers consider that this has created an attractive buying opportunity, and they remain very constructive on the outlook for WPC's holdings. They believe that there is a disconnect between Asian equity prices and corporate earnings, which continue to grow at a healthy pace. The managers are finding what they consider to be exciting investment opportunities in the region, including in Japan and China, where its stock market has suffered disproportionately due to concerns about global trade as a result of the US's 'America First' policy.

 

WPC's shares are currently trading at a 15.1% discount to cum-income NAV, which is towards the wide end of the 7.3% to 18.4% range over the last five years. The board buys back shares when they are trading at a substantial and anomalous discount; the rate of share repurchases has increased in recent months. WPC has a progressive dividend policy, its annual distribution has increased for the last 13 consecutive years, and the trust currently offers a yield of 1.9%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFKBDNBBDDQDK
Date   Source Headline
17th Mar 20203:47 pmRNSMonthly Factsheet as at 29 February 2020
17th Mar 20209:49 amRNSNet Asset Value(s)
16th Mar 20205:18 pmRNSTransaction in Own Shares
16th Mar 202011:52 amRNSNet Asset Value(s)
13th Mar 202012:53 pmRNSNet Asset Value(s)
12th Mar 202012:14 pmRNSNet Asset Value(s)
11th Mar 202011:35 amRNSNet Asset Value(s)
10th Mar 202012:07 pmRNSNet Asset Value(s)
9th Mar 202011:06 amRNSNet Asset Value(s)
6th Mar 202011:27 amRNSNet Asset Value(s)
5th Mar 202012:02 pmRNSNet Asset Value(s)
4th Mar 202011:02 amRNSNet Asset Value(s)
3rd Mar 20204:33 pmRNSPortfolio Holdings as at 30 November 2019
3rd Mar 202011:08 amRNSNet Asset Value(s)
2nd Mar 20204:34 pmRNSTotal Voting Rights
2nd Mar 202010:53 amRNSNet Asset Value(s)
28th Feb 202010:53 amRNSNet Asset Value(s)
27th Feb 20201:47 pmRNSNet Asset Value(s)
26th Feb 202011:30 amRNSNet Asset Value(s)
25th Feb 202012:36 pmRNSNet Asset Value(s)
24th Feb 202010:49 amRNSNet Asset Value(s)
21st Feb 202012:05 pmRNSNet Asset Value(s)
20th Feb 202011:49 amRNSNet Asset Value(s)
19th Feb 202011:31 amRNSNet Asset Value(s)
18th Feb 20209:59 amRNSNet Asset Value(s)
17th Feb 202012:14 pmRNSNet Asset Value(s)
17th Feb 202010:24 amRNSMonthly Factsheet as at 31 January 2020
14th Feb 202011:10 amRNSNet Asset Value(s)
13th Feb 202012:18 pmRNSNet Asset Value(s)
13th Feb 202010:31 amRNSHolding(s) in Company
12th Feb 202012:47 pmRNSNet Asset Value(s)
11th Feb 20205:15 pmRNSTransaction in Own Shares
11th Feb 20203:34 pmRNSPortfolio Listing as at 31 October 2019
11th Feb 202010:58 amRNSNet Asset Value(s)
10th Feb 20205:15 pmRNSTransaction in Own Shares
10th Feb 20202:03 pmRNSNet Asset Value(s)
7th Feb 20205:36 pmRNSTransaction in Own Shares
7th Feb 202011:34 amRNSNet Asset Value(s)
6th Feb 202010:41 amRNSNet Asset Value(s)
5th Feb 202010:07 amRNSNet Asset Value(s)
4th Feb 202010:40 amRNSNet Asset Value(s)
3rd Feb 202011:41 amRNSTotal Voting Rights
3rd Feb 202010:39 amRNSNet Asset Value(s)
31st Jan 202010:45 amRNSNet Asset Value(s)
30th Jan 20205:04 pmRNSTransaction in Own Shares
30th Jan 20201:04 pmRNSNet Asset Value(s)
29th Jan 202012:26 pmRNSNet Asset Value(s)
28th Jan 202012:22 pmRNSNet Asset Value(s)
27th Jan 20205:37 pmRNSTransaction in Own Shares
27th Jan 202012:14 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.